
Company profile · Onderzoeks- & kennisinstelling
Netherlands Translational Research Center
- Research
- Onderzoeks- & kennisinstelling
- Oss
- Research · Oss
- Employees
- 11–50
- Founded
- 2021
- Province
- Noord-Brabant
- Country
- Netherlands
About Netherlands Translational Research Center
Oncolines is a precision medicine services company in oncology and cancer immunotherapy. We offer a set of complementary services to enable our clients to determine the activity, selectivity and mechanism of action of drugs and drug candidates. Our technology platforms for services comprise cancer cell panel profiling, drug combination testing, bioinformatics, flow cytometry, DNA and RNA sequencing, generation of drug resistant cell lines, target residence time determination, kinase profiling and more. We are experts in the discovery of drug response biomarkers. With Oncolines® cancer cell panel profiling and bioinformatics, we identify predictive drug response biomarkers, new disease indications and synergistic drug combinations. We present data in a unique interactive reporting format to facilitate easier and faster interpretation of results. We help cancer researchers to move their projects to the clinic faster.
Keywords
- Assay Development
- Cell-Based Assays
- Kinetic Binding Experiments
- Medicinal Chemistry
- Neurodegenerative Disease
- Oncology
- Protein Crystallography
Address
Headquarters
Kloosterstraat 9 (visiting address)5349AB OssNoord-Brabant, Netherlands
Similar companies
Companies with a similar profile, Noord-Brabant first.

Oncolines B.V.
Biotechnology · Oss
11–50 employeesView profile
Genetic Tools Europe B.V.
Medical Devices · Rosmalen
2–10 employeesView profile

Flindr Therapeutics
Biotechnology · Oss
2–10 employeesView profile

Flindr formerly Immagene
Biotechnology · Oss
2–10 employeesView profile
InnoSIGN
Biotechnology · Eindhoven
11–50 employeesView profile

Sysmex Life Science NL/BE
Medical Devices · Etten-Leur
51–200 employeesView profile